Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ribavirin: a clinical overview.

H Fernandez, G Banks, R Smith

    European Journal of Epidemiology
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Ribavirin is a versatile antiviral drug effective against numerous RNA and DNA viruses. It shows significant success in treating respiratory syncytial virus, influenza, and Lassa fever, reducing mortality by over 90%.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification of Farmland Bird Indicator Species for Practitioner Monitoring in the United Kingdom.

    Ecology and evolution·2025
    Same author

    Aperiodic neural activity is a biomarker for depression severity.

    medRxiv : the preprint server for health sciences·2023
    Same author

    Author Correction: Universal DNA methylation age across mammalian tissues.

    Nature aging·2023
    Same author

    Universal DNA methylation age across mammalian tissues.

    Nature aging·2023
    Same author

    A missense mutation in Katnal1 underlies behavioural, neurological and ciliary anomalies.

    Molecular psychiatry·2017
    Same author

    [Does repeated endometrial destruction procedure decrease abnormal uterine bleeding, and does it reduce the number of hysterectomies in this indication?].

    Journal de gynecologie, obstetrique et biologie de la reproduction·2013
    Same journal

    Re: "Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study".

    European journal of epidemiology·2026
    Same journal

    Separability and identifiability as primary obstacles to substantively useful mediation analysis.

    European journal of epidemiology·2026
    Same journal

    Intergenerational income mobility and psychotropic drug dispensation in a 1953 Stockholm cohort: a diagonal reference model approach.

    European journal of epidemiology·2026
    Same journal

    Genetic risk score to enhance glaucoma case detection: a prospective double-blind screening study (EyeLife) in the population-based Lifelines cohort.

    European journal of epidemiology·2026
    Same journal

    Different risks, same causes: educational attainment influences when, not from what, we die.

    European journal of epidemiology·2026
    Same journal

    Loneliness around the world: patterns, predictors, and well-being implications.

    European journal of epidemiology·2026
    See all related articles

    Area of Science:

    • Virology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Ribavirin is a broad-spectrum antiviral agent.
    • It exhibits activity against a wide range of RNA and DNA viruses.
    • Its mechanism of action, pharmacokinetics, and toxicity are key areas of study.

    Purpose of the Study:

    • To present preclinical toxicity, safety, and clinical efficacy studies of ribavirin.
    • To highlight ribavirin's effectiveness in treating specific viral infections.
    • To discuss the drug's potential in managing severe and life-threatening viral diseases.

    Main Methods:

    • Review of preclinical toxicity, safety, and clinical efficacy studies.
    • Analysis of ribavirin's pharmacokinetic and mechanism of action data.

    Related Experiment Videos

  • Evaluation of clinical trial results for various viral infections.

    • Main Results:

    • Ribavirin shows significant efficacy in treating respiratory syncytial virus in infants and influenza A and B in young adults.
    • Successful use of ribavirin aerosol in immunodeficient children with viral pneumonia.
    • Demonstrated over 90% mortality reduction in Lassa fever patients, surpassing supportive care or immune plasma.

    Conclusions:

    • Ribavirin is a highly effective antiviral agent with a broad spectrum of activity.
    • It offers significant clinical benefits for severe viral infections, including Lassa fever.
    • Further controlled trials are investigating its efficacy against AIDS virus and other viral infections.